- PureTech Health (PRTC, Financial) to announce its 2024 annual financial results on April 30, 2025.
- The company will host a conference call and webcast at 9:00 AM EDT / 2:00 PM BST on the results day.
- PureTech Health is listed on both Nasdaq and the London Stock Exchange under the ticker PRTC.
PureTech Health plc (PRTC), a clinical-stage biotherapeutics company, has scheduled the release of its annual financial results for the year ended December 31, 2024, on Wednesday, April 30, 2025. The announcement will be followed by a presentation and conference call at 9:00 AM EDT / 2:00 PM BST, providing insights into the company's financial performance and developments. Interested parties can access the webcast of the presentation via the company's investor relations website.
PureTech Health is renowned for its innovative approach to medicine, focusing on the development of new therapeutic candidates to treat devastating diseases. Its comprehensive R&D pipeline comprises 29 therapeutics, including three that have received FDA approval. The company continues to advance several programs through various clinical stages, leveraging its strong network of scientists and industry leaders.
Listed on both the Nasdaq and the London Stock Exchange, PureTech Health (PRTC, Financial) remains a significant player in the biotechnology sector. The forthcoming financial results will provide critical insights into the company's progress and future strategies.
